Sunday, September 21, 2014

medpage TODAY: FDA Panel – Myalept OK for Narrow Indication

medpage TODAY, Dec. 12, 2013

Dr. Dennis Ownby was featured on medpage TODAY as an expert panelist on the FDA’s endocrinologic and metabolic drugs advisory committee.

Read: FDA Panel: Myalept OK for Narrow Indication.

Leave a Reply